Back to search
FDAFDA · Food and drugs·Recall number D-0830-2020

Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01

Published February 12, 2020 · Recall initiated: January 27, 2020

Summary

FDA records drug Class II recall D-0830-2020, published February 12, 2020 and initiated January 27, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 22,868 bottles; Lot: Lot #: 1281203M, exp. date 03/2020 and 1290113M, exp. date 04/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

GMP Deviations: Product bottle may be absent of desiccant.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide within the United States
Lot
Lot #: 1281203M, exp. date 03/2020 and 1290113M, exp. date 04/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01 recalled?

Yes. FDA published recall D-0830-2020 on February 12, 2020. Reported hazard: GMP Deviations: Product bottle may be absent of desiccant.

What should I do if I have this product?

Voluntary: Firm initiated · Letter